Diabetes Technology and Therapeutics
Subject Categories
Aims & Scope
Abstracting & Indexing
Detailed Metrics
| Total Docs. (latest) | 222 |
| Total Docs. (3 years) | 432 |
| Total Refs. | 7,091 |
| Total Citations (3 years) | 2,681 |
| Citable Docs. (3 years) | 389 |
| Citations / Doc. (2 years) | 6.68 |
| Ref. / Doc. | 31.94 |
| % Female | 52.7% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Top 10 Most Cited Articles
Frequently Asked Questions
What is the impact factor of Diabetes Technology and Therapeutics?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Diabetes Technology and Therapeutics has an SJR of 2.663 and is ranked Q1.
What is the SJR and quartile of Diabetes Technology and Therapeutics?
Diabetes Technology and Therapeutics has an SJR (SCImago Journal Rank) of 2.663 and its best quartile is Q1.
What is the H-index of Diabetes Technology and Therapeutics?
The H-index of Diabetes Technology and Therapeutics is 116, meaning 116 of its articles have each been cited at least 116 times.
Is Diabetes Technology and Therapeutics indexed in Scopus?
Yes. Diabetes Technology and Therapeutics is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.